2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)

Journal of Medicinal Chemistry
D W HansenB S Pitzele

Abstract

An attractive approach to the treatment of inflammatory conditions such as osteo- and rheumatoid arthritis, inflammatory bowel disease, and sepsis is through the selective inhibition of human inducible nitric oxide synthase (hiNOS) since localized excess nitric oxide (NO) release has been implicated in the pathology of these diseases. A series of monosubstituted iminohomopiperidinium salts possessing lipophilic functionality at ring positions 3, 5, 6, and 7 has been synthesized, and series members have demonstrated the ability to inhibit the hiNOS isoform with an IC50 as low as 160 nM (7). Compounds were found that selectively inhibit hiNOS over the human endothelial constitutive enzyme (heNOS) with a heNOS/hiNOS IC50 ratio in excess of 100 and as high as 314 (9). Potencies for inhibition of hiNOS and the human neuronal constitutive enzyme (hnNOS) are comparable. Substitution in the 3 and 7 positions provides compounds that exhibit the greatest degree of selectivity for hiNOS and hnNOS over heNOS. Submicromolar potencies for 6 and 7 in a mouse RAW cell assay demonstrated the ability of these compounds to inhibit iNOS in a cellular environment. These latter compounds were also found to be orally bioavailable and efficacious due ...Continue Reading

References

Oct 1, 1993·Analytical Biochemistry·T P MiskoM G Currie
Jan 1, 1994·Medicinal Research Reviews·J F Kerwin, M Heller
Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Jun 24, 1994·Journal of Medicinal Chemistry·M A Marletta
Nov 11, 1994·Journal of Medicinal Chemistry·W M MooreM G Currie
Jan 1, 1994·Annual Review of Biochemistry·D S Bredt, S H Snyder
Jan 24, 1995·European Journal of Pharmacology·J R ConnorM G Currie
Jan 1, 1995·Annual Review of Physiology·O W Griffith, D J Stuehr
Mar 16, 1993·European Journal of Pharmacology·T P MiskoM G Currie
Dec 8, 1994·Nature·S H Snyder
Nov 30, 1995·European Journal of Pharmacology·G J SouthanC Thiemermann

❮ Previous
Next ❯

Citations

Dec 31, 2003·Bioorganic & Medicinal Chemistry Letters·Shigeo UedaMotoji Kawasaki
Aug 12, 1999·European Journal of Pharmacology·J C StocletA L Kleschyov
Sep 12, 2001·Bioorganic & Medicinal Chemistry Letters·A E MoormannR K Webber
Jul 21, 2001·The Biochemical Journal·W K AldertonR G Knowles
Jan 8, 2008·Arthritis Research & Therapy·Raimund W KinneGerd-R Burmester
Nov 30, 2000·Arthritis Research·R W KinneG R Burmester
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Julie E GoodwinWilliam C Sessa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.